Alzamend Neuro Inc (ALZN) — Cash Flow-to-Debt Ratio
Alzamend Neuro Inc (ALZN) has a Cash Flow-to-Debt Ratio of -0.93x as of January 2026, meaning its operating cash flow of $-1.74 Million could theoretically repay -1% of its total liabilities ($1.86 Million) in one year. See Alzamend Neuro Inc (ALZN) liquidity to equity ratio to evaluate short-term liquidity relative to the company's equity base.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Alzamend Neuro Inc Cash Flow-to-Debt Ratio (2016–2025)
Historical debt coverage capacity for Alzamend Neuro Inc across 10 annual periods. Also explore Alzamend Neuro Inc net asset momentum to track the company's year-over-year net asset growth rate.
Annual Cash Flow-to-Debt Ratio for Alzamend Neuro Inc (2016–2025)
Year-by-year debt coverage analysis for Alzamend Neuro Inc. For market capitalisation and broader financial context, see how much is Alzamend Neuro Inc worth.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -10.35x | $-6.57 Million | $634.76K | ▼ -303.6% |
| 2024 | -2.56x | $-8.27 Million | $3.23 Million | ▲ +17.5% |
| 2023 | -3.11x | $-8.92 Million | $2.87 Million | ▲ +45.2% |
| 2022 | -5.68x | $-6.61 Million | $1.16 Million | ▼ -88.3% |
| 2021 | -3.01x | $-2.71 Million | $899.64K | ▼ -27.5% |
| 2020 | -2.36x | $-2.35 Million | $992.31K | ▼ -167.8% |
| 2019 | -0.88x | $-1.05 Million | $1.18 Million | ▲ +95.8% |
| 2018 | -21.21x | $-2.05 Million | $96.72K | ▼ -973.9% |
| 2017 | -1.98x | $-1.42 Million | $717.22K | ▼ -228.1% |
| 2016 | -0.60x | $-18.49K | $30.72K | — |